Literature DB >> 34992259

Comparing development strategies for PD1/PDL1-based immunotherapies.

Guanqiao Li, Yale Jiang, Yunhe Qin, Shuona Yuan, Xiaoyuan Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34992259     DOI： 10.1038/d41573-022-00003-7

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   112.288


× No keyword cloud information.
  2 in total

Review 1.  Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States.

Authors:  Huiyao Huang; Qi Zhu; Man Ga; Dawei Wu; Xinyu Meng; Shuhang Wang; Hong Fang; Yu Tang; Ning Li
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

2.  Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022.

Authors:  Si Wu; Hansheng Bai; Ling Zhang; Jiamin He; Xiangru Luo; Shiyi Wang; Guangjun Fan; Na Sun
Journal:  Front Cardiovasc Med       Date:  2022-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.